Belgium – Pharmaceutical products – Supply of antiviral to respond to the Andes Hantavirus outbreak
Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency
Buyer country
Belgium
Publication date
Not specified
Biderra sector
Pharma and laboratory
Data source
TED open data
Decision signals
First-pass opportunity review
These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.
- Timing signal
- Deadline not indexed
- Indexed data completeness
- 71%
- Official title coverage
- 7 languages
- Classification signal
- 33600000
Check the official notice
Based on seven decision fields
Preserved from source-supplied versions
Medical equipment, pharmaceuticals and personal care products
Official title versions
TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.
Bélgica – Productos farmacéuticos – Supply of antiviral to respond to the Andes Hantavirus outbreak
België – Farmaceutische producten – Supply of antiviral to respond to the Andes Hantavirus outbreak
Belgia – Produkty farmaceutyczne – Supply of antiviral to respond to the Andes Hantavirus outbreak
Belgique – Produits pharmaceutiques – Supply of antiviral to respond to the Andes Hantavirus outbreak
Belgien – Arzneimittel – Supply of antiviral to respond to the Andes Hantavirus outbreak
Belgio – Prodotti farmaceutici – Supply of antiviral to respond to the Andes Hantavirus outbreak
Belgium – Pharmaceutical products – Supply of antiviral to respond to the Andes Hantavirus outbreak
What Biderra adds
For notice 592412-2026, Biderra has normalized the contracting authority country as Belgium, grouped CPV 33600000 under pharma and laboratory, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.